Você procurou por: allopurinol (Maltês - Inglês)

allopurinol
adenuric 80 mg qd 48% *

plaċebo + allopurinol
placebo + allopurinol

mediċini għall-gotta (allopurinol)
gout medicines (allopurinol)

inti għandek tuża zurampic flimkien ma’ allopurinol jew febuxostat.
you must use zurampic together with either allopurinol or febuxostat.

allopurinol jew febuxostat (użati fil-kura tal-gotta)
allopurinol or febuxostat (used to treat gout)

fluoxetine, allopurinol, simpatolitiċi, cyclo-, tro-and iphosphamides,
fluoxetine, allopurinol, sympatholytics, cyclo-, tro-and iphosphamides,

l- użu ta ’ allopurinol flimkien ma ’ xeloda għandu jiġi evitat.
concomitant use of allopurinol with xeloda should be avoided.

huwa rrakkomandat li tittieħed doża ta’ 100 mg ta’ allopurinol kuljum mill-ħalq.
a daily oral dose of 100 mg of allopurinol is recommended for a period of 2 weeks.

il-pazjenti ħadu jew adenuric jew allopurinol għal perjodu ta' bejn sebat u disat ijiem.
patients received either adenuric or allopurinol for 7 to 9 days.

prodotti mediċinali użati fil-kura għal gotta (eż. probenecid, sulfinpyrazone u allopurinol)
medicinal products used in the treatment for gout (e.g. probenecid, sulfinpyrazone and allopurinol)

alkalinizzazzjoni aggressiva tal-awrina u l-użu ta’ allopurinol jistgħu jipprevjenu nefropatija urate.
aggressive alkalinisation of the urine and use of allopurinol can prevent urate nephropathy.

mediċini għall-kura ta' puplesiji jew rogħda bħal phenytoin mediċini li jikkuraw il-gotta bħal allopurinol
medicines for the treatment of seizures or tremors such as phenytoin medicines that treat gout such as allopurinol

l- użu ta 'allopurinol għandu jiġi kkunsidrat f' pazjenti b' riskju ta' iperuriċemija.
for patients at risk of hyperuricemia, the use of allopurinol should be considered.

ir-riżultati wrew li fasturtec, meta mqabbel ma’ allopurinol, kellu azzjoni sinifikament aktar qawwija u bikrija.
results showed a significantly more rapid onset of action of fasturtec in comparison with allopurinol.

għall-individwi b’indeboliment renali li kienu randomised għal allopurinol, id-doża kienet mgħollija sa 100 mg qd.
for renally impaired subjects who were randomized to allopurinol, the dose was capped at 100 mg qd.

nota: 509 pazjent irċievew allopurinol 300 mg qd; 10 pazjenti bi krejatinina fis-serum >1.5 u <
note: 509 patients received allopurinol 300 mg qd; 10 patients with serum creatinine >1.5 and <

adenuric wera tnaqqis superjuri u attività aktar mgħaġġla biex jitnaqqas l-urate minn allopurinol waqt li ppreserva l-funzjoni tal-kliewi.
adenuric showed a superior and faster urate lowering activity compared to allopurinol.

adenuric kien iktar effikaċi minn allopurinol u mill- plaċebo fit- tnaqqis tal- livelli ta 'aċidu uriku fid - demm.
adenuric was more effective than allopurinol and placebo in reducing blood uric acid levels.

jekk għandek jew qatt kellek mard renali u/jew reazzjoni allerġika serja għal allopurinol (medikazzjoni li tintuża għall-kura tal-gotta)
if you have or have had renal disease and/or serious allergic reaction to allopurinol (a medication used for the treatment of gout)

interazzjonijiet ma’ allopurinol ġew osservati għal 5-fu; bi tnaqqis possibbli ta’ l-effikaċja ta’ 5-fu.
iinteractions with allopurinol have been observed for 5-fu; with possible decreased efficacy of 5-fu.